SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
1-Year Return
8.73%
This Quarter Return
+3.5%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$558M
AUM Growth
-$32.6M
(-5.5%)
Cap. Flow
-$67.8M
Cap. Flow
% of AUM
-12.15%
Top 10 Holdings %
Top 10 Hldgs %
79.3%
Holding
134
New
55
Increased
22
Reduced
29
Closed
18
Top Buys
| 1 |
IBDO
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
|
$20.2M |
| 2 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
$19.7M |
| 3 |
Plains GP Holdings
PAGP
|
$13.8M |
| 4 |
Simplify Aggregate Bond ETF
AGGH
|
$4.29M |
| 5 |
Athira Pharma
ATHA
|
$3.48M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$157M |
| 2 |
Simplify Intermediate Term Treasury Futures Strategy ETF
TYA
|
$3.77M |
| 3 |
Invesco QQQ Trust
QQQ
|
$3.05M |
| 4 |
Cigna
CI
|
$2.93M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
$2.72M |
Sector Composition
| 1 | Healthcare | 13.33% |
| 2 | Energy | 2.48% |
| 3 | Technology | 0.58% |
| 4 | Consumer Discretionary | 0.15% |
| 5 | Industrials | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Akero Therapeutics
AKRO
$3.52B
| $2.29M | 0.33% |
+59,777
| New | +$2.29M |
|
|
SAGE
27
DELISTED
Sage Therapeutics
SAGE
| $2.1M | 0.3% |
+50,030
| New | +$2.1M |
|
28
Medtronic
MDT
$119B
| $1.99M | 0.29% |
24,723
+17,391
| +237% | +$1.4M |
|
29
Applied Therapeutics
APLT
$67M
| $1.93M | 0.28% |
+2,382,621
| New | +$1.93M |
|
30
Avidity Biosciences
RNA
$6.24B
| $1.92M | 0.28% |
+125,000
| New | +$1.92M |
|
31
Johnson & Johnson
JNJ
$431B
| $1.88M | 0.27% |
12,124
-3,662
| -23% | -$568K |
|
32
SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.78B
| $1.87M | 0.27% |
+61,480
| New | +$1.87M |
|
33
Eli Lilly
LLY
$666B
| $1.87M | 0.27% |
5,437
-2,215
| -29% | -$761K |
|
34
Kayne Anderson Energy Infrastructure Fund
KYN
$2.08B
| $1.83M | 0.26% |
+212,238
| New | +$1.83M |
|
35
Fulcrum Therapeutics
FULC
$372M
| $1.82M | 0.26% |
+639,118
| New | +$1.82M |
|
36
Simplify Stable Income ETF
BUCK
$346M
| $1.79M | 0.26% |
71,759
+51,387
| +252% | +$1.29M |
|
37
Simplify Enhanced Income ETF
HIGH
$192M
| $1.78M | 0.26% |
71,332
+50,880
| +249% | +$1.27M |
|
38
Phathom Pharmaceuticals
PHAT
$851M
| $1.7M | 0.24% |
+237,935
| New | +$1.7M |
|
39
Mirum Pharmaceuticals
MIRM
$3.73B
| $1.68M | 0.24% |
+70,000
| New | +$1.68M |
|
40
IQVIA
IQV
$31.3B
| $1.6M | 0.23% |
8,025
+5,154
| +180% | +$1.03M |
|
41
AbbVie
ABBV
$376B
| $1.54M | 0.22% |
9,646
+3,893
| +68% | +$620K |
|
42
Zimmer Biomet
ZBH
$20.8B
| $1.51M | 0.22% |
+11,697
| New | +$1.51M |
|
43
Becton Dickinson
BDX
$54.8B
| $1.5M | 0.22% |
6,065
+2,672
| +79% | +$661K |
|
44
Idexx Laboratories
IDXX
$51.2B
| $1.47M | 0.21% |
+2,939
| New | +$1.47M |
|
45
UnitedHealth
UNH
$281B
| $1.26M | 0.18% |
2,662
-5,335
| -67% | -$2.52M |
|
46
Allogene Therapeutics
ALLO
$246M
| $1.21M | 0.17% |
+245,000
| New | +$1.21M |
|
47
TScan Therapeutics
TCRX
$107M
| $1.15M | 0.16% |
+546,916
| New | +$1.15M |
|
48
Cooper Companies
COO
$13.5B
| $1.14M | 0.16% |
12,164
+5,460
| +81% | +$510K |
|
49
DexCom
DXCM
$31.7B
| $1.1M | 0.16% |
9,488
-12,086
| -56% | -$1.4M |
|
|
MRNS
50
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.04M | 0.15% |
+150,000
| New | +$1.04M |
|